LAWSUITS NEWS & LEGAL INFORMATION
Amiodarone and Simvastatin Legal News Articles & Interviews
June 8, 2011. By Heidi Turner.
Read [ FDA Announces Safety Changes for Simvastatin ]
Washington, DC The US Food and Drug Administration (FDA) has announced a change in the safety label for simvastatin (sold under the brand-name Zocor) because high-dose simvastatin has been linked to an increased risk of myopathy. The FDA recommends that 80 mg simvastatin, the highest dose approved by the FDA, only be used in patients who have already taken the dose for 12 months or more and have not developed muscle toxicity. Furthermore, the 80 mg simvastatin dose should not be prescribed to new patients.
February 21, 2011. By Charles Benson.
Read [ Scientists Discover Previously Unknown Simvastatin Effect ]
Utica, NY Scientists at the Masonic Medical Research Laboratory in Utica, New York, recently discovered a potential benefit of simvastatin in suppressing the occurrence of some forms of abnormal heart rhythms, reports WKTV, a local NBC affiliate.
February 11, 2011. By Heidi Turner.
Read [ Amiodarone or Multaq: Where Should Patients Turn? ]
Portland, OR When it comes to taking amiodarone, much of the concern is about amiodarone and simvastatin interaction. Although it is true that the combination of amiodarone and simvastatin can cause complications, amiodarone by itself has reportedly been linked to an increased risk of pulmonary toxicity, which could potentially be deadly.
January 22, 2011. By Charles Benson.
Read [ French Company to Warn US Doctors of Side Effects of Drug Similar to Amiodarone ]
Paris, France France's largest drugmaker, Sanofi-Aventis SA, is expected to send a letter to US doctors to inform them of two cases of liver failure in patients taking a drug similar to amiodarone, Bloomberg reports.
January 9, 2011. By Heidi Turner.
Read [ Amiodarone: When Off-Label Drug Use Hurts Patients ]
Washington, DC When it comes to medications such as amiodarone, what the patient does not know can definitely hurt him. Problems with amiodarone, such as amiodarone side effects and amiodarone interactions with other drugs, have reportedly put patient's lives at risk. The worst part might be that many of them were prescribed the medication for off-label use.
January 4, 2011. By Heidi Turner.
Read [ Amiodarone: Father Went into Hospital and Never Came Out ]
Houston, TX When Robert R. was put on amiodarone, his family thought the drug was necessary to treat his condition. They did not realize that, because of amiodarone side effects, the US Food and Drug Administration (FDA) had only approved amiodarone as a drug of last resort. Furthermore, they did not realize that the drug could result in amiodarone lung toxicity and was only approved for patients with life-threatening ventricular arrhythmia, which Robert did not have.
December 20, 2010. By Gordon Gibb.
Read [ Amiodarone Interaction with Simvastatin Still a Global Concern ]
Shanghai, China The Republic of China has now caught on to the pre-existing concern over simvastatin when combined with amiodarone, given a release in November by the State Food and Drug Administration (SFDA) in China warning about the risk of rhabdomyolysis, a rare muscle injury that can lead to kidney failure and death. Simvastatin taken alone in high doses, or taken together with amiodarone, can cause grievous health issues.
November 19, 2009. By Gordon Gibb.
Read [ Amiodarone and Simvastatin Anything But a Dynamic Duo ]
Kansas City, MO The relationship between simvastatin and amiodarone, together with the amiodarone interaction identified as simvastatin rhabdomyolysis, came to the forefront in August of last year when the FDA issued an alert to health care professionals regarding the risk for rhabdomyolysis when simvastatin is used in association with amiodarone.
November 4, 2009. By Charles Benson.
Read [ Off-label use of Amiodarone may be dangerous ]
Silver Spring, MD According to the FDA, one in five U.S. doctors who write prescriptions from common use drugs do so for off-label use, which is what has allegedly occurred with the irregular heartbeat medication Amiodarone.
October 18, 2009. By Gordon Gibb.
Read [ Amiodarone + Simvastatin = Increased Risk: FDA ]
Washington, DC An adverse reaction to statin use, including amiodarone interaction and simvastatin side effect, was identified by the US Food and Drug Administration (FDA) last year. And while simvastatin rhabdomyolysis is rare, researchers from the University of Western Ontario warned that side effects are likely to increase as more patients were prescribed amiodarone, and as LDL cholesterol targets tightened.
- FDA: Simvastatin and Amiodarone Don't Mix By Gordon Gibb (Aug-9-08)